Biopolym. Cell. 2012; 28(6):456-460.
Genomics, Transcriptomics and Proteomics
Transcriptional and post-transcriptional control of eEF1A2 expression during myoblast diffrerentiation
1Vislovukh A. A., 2Groisman I. S., 1El'skaya A. V., 1Negrutskii B. S., 2Polesskaya A. N.
  1. State Key Laboratory of Molecular and Cellular Biology
    Institute of Molecular Biology and Genetics, NAS of Ukraine
    150, Akademika Zabolotnoho Str., Kyiv, Ukraine, 03680
  2. CNRS FRE 3377 and Universite Paris-Sud, CEA
    Saclay, F-91191 Gif-sur-Yvette, France


During postnatal development, the switch of the expression from isoform A1 to the isoform A2 of eukaryotic translation elongation factor (eEF1A) is observed in neuronal and muscle tissues. The switch of the expression is a vital fundamental process, as mutant mice, with the partial EEF1A2 deletion dies on the 28th day after birth. Mechanism of the inhibition of A1 and stimulation of A2 expression during the first days of postnatal development is unknown. The existence of potential miRNA binding sites in the 3’UTR of mRNAs encoding the isoforms assumes a post-transcriptional control of abovementioned phenomenon. Aim. To check the possibility of post-transcriptional regulation of the isoforms A1 and A2 expression during differentiation of the human immortalized myoblasts cell line LHCN. Methods. The level of gene expression was quantified by qPCR, the existence of post-transcriptional regulation was demonstrated with Dual-Luciferase® Reporter Assay. Results. Using immortalized human myoblasts cell line LHCN, the induction of isoform A2 of eEF1 during differentiation of myoblasts was shown. The existence of transcriptional and post-transcriptional control of the abovementioned process was confirmed. Downregulation of mir-661 and mir-744 that have binding sites in the 3’ UTR of EEF1A2 mRNA, during differentiation suggests a potential role of microRNAs in the eEF1A2 induction during myoblast differentiation. Conclusions. Induction of A2 isoform of eEF1 during differentiation of myoblasts occurs on transcriptional and post-transcriptional level.
Keywords: eEF1A1, eEF1A2, immortalized human myoblasts LHCN, differentiation, microRNA


[1] Negrutskii B. S., El'skaya A. V. 1998 Eukaryotic translation elongation factor 1 alpha: structure, expression, functions, and possible role in aminoacyl-tRNA channeling Prog. Nucleic Acid Res. Mol. Biol 60:47–78.
[2] Merrick W. C. 1992 Mechanism and regulation of eukaryotic protein synthesis Microbiol. Rev 56, N 2:291–315.
[3] Lee S., Francoeur A. M., Liu S., Wang E. 1992 Tissue-specific expression in mammalian brain, heart, and muscle of S1, a member of the elongation factor-1 alpha gene family J. Biol. Chem 267, N 33:24064–24068.
[4] Novosylna A. V., Timchenko A. A., Tiktopulo E. I., Serdyuk I. N., Negrutskii B. S., El'skaya A. V. 2007 Characterization of physical properties of two isoforms of translation elongation factor 1A Biopolym. Cell 23, N 5:386–390
[5] Lee S., Wolfraim L. A., Wang E. 1993 Differential expression of S1 and elongation factor-1 alpha during rat development J. Biol. Chem 268, N 32:24453–24459.
[6] Lee S., Stollar E., Wang E. 1993 Localization of S1 and elongation factor-1 alpha mRNA in rat brain and liver by non-radioactive in situ hybridization J. Histochem. Cytochem 41, N 7 P. 1093–1098.
[7] Newbery H. J., Loh D. H., O'Donoghue J. E., Tomlinson V. A., Chau Y. Y., Boyd J. A., Bergmann J. H., Brownstein D., Abbott C. M. 2007 Translation elongation factor eEF1A2 is essential for post-weaning survival in mice J. Biol. Chem 282, N 39:28951–28959.
[8] Mateyak M. K., Kinzy T. G. 2010 eEF1A: thinking outside the ribosome J. Biol. Chem 285, N 28:21209–21213.
[9] Futernyk P. V., Negrutskii B. S., El'ska G. V. 2008 Noncanonical complexes of mammalian eEF1A with various deacylated tRNAs Biopolym. Cell 24, N 6:453–462.
[10] Ruest L. B., Marcotte R., Wang E. 2002 Peptide elongation factor eEF1A-2/S1 expression in cultured differentiated myotubes and its protective effect against caspase-3-mediated apoptosis J. Biol. Chem 277, N 7:5418–5425.
[11] Anand N., Murthy S., Amann G., Wernick M., Porter L. A., Cukier I. H., Collins C., Gray J. W., Diebold J., Demetrick D. J., Lee J. M. 2002 Protein elongation factor EEF1A2 is a putative oncogene in ovarian cancer Nat. Genet 31, N 3:301–305.
[12] Lee M. H., Surh Y. J. 2009 eEF1A2 as a putative oncogene Ann. N. Y. Acad. Sci 1171:87–93.
[13] Ambros V. 2004 The functions of animal microRNAs Nature 431, N 7006:350–355.
[14] Zhu C. H., Mouly V., Cooper R. N., Mamchaoui K., Bigot A., Shay J. W., Di Santo J. P., Butler-Browne G. S., Wright W. E. 2007 Cellular senescence in human myoblasts is overcome by human telomerase reverse transcriptase and cyclin-dependent kinase 4: consequences in aging muscle and therapeutic strategies for muscular dystrophies Aging Cell 6, N 4:515–523.
[15] Grassi G., Scaggiante B., Farra R., Dapas B., Agostini F., Baiz D., Rosso N., Tiribelli C. 2007 The expression levels of the translational factors eEF1A 1/2 correlate with cell growth but not apoptosis in hepatocellular carcinoma cell lines with different differentiation grade Biochimie 89, N 12:1544–1552.
[16] Chen J. F., Callis T. E., Wang D. Z. 2009 microRNAs and muscle disorders J. Cell Sci 122, Pt 1:13–20.
[17] Newbery H. J., Stancheva I., Zimmerman L. B., Abbott C. M. 2011 Evolutionary importance of translation elongation factor eEF1A variant switching: eEF1A1 down-regulation in muscle is conserved in Xenopus but is controlled at a post-transcriptional level Biochem. Biophys. Res. Commun 411, N 1:19–24.
[18] Suryawan A., Davis T. A. 2011 Regulation of protein synthesis by amino acids in muscle of neonates Front. Biosci 16:1445– 1460.
[19] Zhu J., Hayakawa A., Kakegawa T., Kaspar R. L. 2001 Binding of the La autoantigen to the 5' untranslated region of a chimeric human translation elongation factor 1A reporter mRNA inhibits translation in vitro Biochim. Biophys. Acta 1521, N 1–3 P. 19–29.